Fujicopian Co., Ltd. (7957) AI Stock Analysis

• Market Cap: ¥2.20B
• Dividend Yield: 5.27%
• Average Volume (3M): 453.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.18
• Revenue Growth: 0.34%
• EPS Growth: N/A
• Country: JP
• Employees: 583
• Sector: Industrials
• Sector Strength: 72
• Industry: Business Equipment & Supplies
• EPS (TTM): -1649.20
• Shares Outstanding: 1,789,487
• 10 Day Avg. Volume: 650
• 30 Day Avg. Volume: 453
• PEG Ratio: <0.01
• Price to Book (P/B): 0.28
• Price to Sales (P/S): 0.27
• P/FCF Ratio: -4.93
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 50 Neutral
• Price Target: ¥1,447.00 ▼(-1.77% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is held back primarily by weak recent financial performance (2025 loss, revenue decline, and negative free cash flow), partially offset by a moderately levered balance sheet. Technical indicators and valuation are both broadly neutral, with a modest dividend yield but losses limiting P/E-based support.

Positive Factors

Recurring consumables revenue

A consumables-focused business generates repeat purchasing tied to customers' printing volumes, creating durable baseline demand. This recurring revenue profile supports predictability of sales, aftermarket customer relationships, and potential steady cash inflows independent of one-off hardware cycles.

Moderate leverage on balance sheet

Relatively low debt-to-equity gives the company financial flexibility to manage cyclical pressure and invest selectively without excessive refinancing risk. Over a 2–6 month horizon this moderate leverage reduces insolvency risk and supports working-capital management during recovery phases.

Proven ability to deliver margins in prior cycles

Historical profitability demonstrates the business model and operations can produce healthy margins when volumes or pricing recover. That operational capacity implies management can restore earnings via cost control, pricing or mix improvements, making a return to profitability feasible within months.

Negative Factors

Sharp 2025 loss and revenue decline

A large recent loss and shrinking topline indicate structural demand or pricing weakness and margin pressure. This reduces internal funding for investments and raises execution risk; restoring revenue and margins is necessary for durable recovery and remains a material short-term fundamental challenge.

Persistently negative free cash flow

Sustained negative free cash flow limits the firm's ability to self-fund capex, inventory, or working capital needs, increasing dependence on external financing. Weak cash conversion undermines flexibility and heightens refinancing and liquidity risk over a 2–6 month horizon if losses persist.

Material decline in equity cushion

A reduced equity base shrinks the company's shock-absorbing capacity and effectively increases leverage ratios, making credit access and covenant headroom tighter. Continued erosion could constrain strategic choices and supplier/customer confidence in the near term.

Fujicopian Co., Ltd. Business Overview & Revenue Model

Company Description

Fujicopian Co., Ltd. manufactures and sells consumable supplies for information and data processing applications in Japan and internationally. The company's products include FIXFILM; and thermal transfer media products, such as thermal color and monochrome ribbons that are used in home fax machines, barcode printers, and various types of ticket dispensing machines. It also provides stationary products comprising correction and glue tapes; fabric ribbons for use in printers and typewriters; correctable film ribbons; and multi-strike film ribbons, as well as analysis and measurement services. The company was incorporated in 1950 and is headquartered in Osaka, Japan.

How the Company Makes Money

Fujicopian generates revenue through the sales of its specialty printing supplies, which include a range of inks, coatings, and adhesives. The company has established key partnerships with major players in the packaging and printing industries, enabling it to secure long-term contracts and bulk orders. Additionally, Fujicopian benefits from a diversified customer base, spanning both domestic and international markets, which helps mitigate risks associated with fluctuations in demand. The company also invests in research and development to innovate and improve its product offerings, thereby enhancing its competitive edge and potentially increasing sales and profitability.

Fujicopian Co., Ltd. Financial Statement Overview

Summary

Overall financials are pressured: the income statement reflects a sharp swing to a large net loss in 2025 with declining revenue and margin compression, and cash flow quality is weak with persistently negative free cash flow in 2022–2025. The balance sheet is a relative strength with moderate leverage, but equity declined materially in 2025, reducing the cushion.

Income Statement

Profitability and growth have been volatile. Revenue declined in 2025 (annual) after modest growth in 2024, and margins compressed versus prior years (gross margin ~21% in 2025 vs ~23% in 2024). Earnings swung sharply to a large net loss in 2025 after a profit in 2024, with operating profit also negative in 2025. Strengths include a prior ability to generate positive margins in 2021–2022 and a meaningful EBITDA margin in 2024, but the recent swing to losses and declining revenue weighs heavily on the score.

Balance Sheet

Leverage appears moderate and generally controlled, with debt-to-equity around ~0.24–0.34 across the period, which is supportive for a cyclical/volatile earnings profile. However, equity declined materially in 2025 versus 2024, consistent with the large loss, reducing the balance-sheet cushion. Overall, the company looks not overly levered, but the recent hit to equity and profitability increases risk if weak operating conditions persist.

Cash Flow

Cash generation has weakened and free cash flow has been persistently negative in recent years. Operating cash flow turned only modestly positive in 2025 (annual) and was negative in 2023, while free cash flow remained negative in 2022–2025 (and improved only sporadically). A key concern is that operating cash flow has been small relative to reported earnings in loss/profit years, indicating weaker cash conversion and/or working-capital or investment pressure. The main positive is that operating cash flow was solid in 2020–2022, but the recent trend is unfavorable.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	8.98B	8.48B	8.98B	8.23B	9.85B	8.60B
Gross Profit	2.17B	1.80B	2.11B	1.36B	2.67B	2.29B
EBITDA	753.64M	436.46M	637.32M	-137.17M	1.09B	894.56M
Net Income	420.64M	-2.70B	397.76M	-856.27M	490.48M	369.65M
Balance Sheet
Total Assets	16.23B	13.87B	16.44B	16.16B	17.82B	16.22B
Cash, Cash Equivalents and Short-Term Investments	3.29B	2.54B	2.86B	3.23B	4.27B	4.33B
Total Debt	3.28B	2.72B	2.80B	2.99B	3.31B	2.96B
Total Liabilities	5.94B	5.90B	5.88B	5.82B	6.69B	5.74B
Stockholders Equity	10.29B	7.97B	10.57B	10.34B	11.14B	10.48B
Cash Flow
Free Cash Flow	0.00	-457.60M	-289.81M	-781.82M	43.59M	317.32M
Operating Cash Flow	0.00	101.91M	299.61M	-46.68M	706.53M	898.64M
Investing Cash Flow	0.00	-532.99M	-248.67M	-778.71M	-988.16M	-728.27M
Financing Cash Flow	0.00	59.60M	-422.06M	-267.47M	40.97M	-451.11M

Fujicopian Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1473.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7957, the sentiment is Negative. The current price of 1473 is above the 20-day moving average (MA) of 1449.05, above the 50-day MA of 1451.62, and above the 200-day MA of 1438.46, indicating a neutral trend. The MACD of -2.75 indicates Positive momentum. The RSI at 46.98 is Neutral, neither overbought nor oversold. The STOCH value of 35.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7957.

Fujicopian Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6448	76 Outperform	¥747.84B	8.32	7.77%	3.16%	4.30%	78.29%
8060	73 Outperform	¥759.14B	18.04	10.50%	2.03%	5.40%	23.70%
7752	71 Outperform	¥773.38B	8.78	6.04%	2.78%	4.46%	70.22%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
4901	58 Neutral	¥3.55T	13.78	7.81%	2.07%	5.39%	12.69%
7957	50 Neutral	¥2.20B	-0.83	―	5.27%	0.34%	―
4902	47 Neutral	¥245.72B	-71.33	-12.69%	0.71%	-11.22%	-731.07%